05:03 PM EDT, 08/14/2025 (MT Newswires) -- Thomas Malley, Director, on August 12, 2025, sold 177,769 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $5,859,815. Following the Form 4 filing with the SEC, Malley has control over a total of 84,513 Class A ordinary shares of the company, with 12,546 shares held directly and 71,967 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/xslF345X05/form4-08142025_080859.xml